Santhera Pharmaceuticals Pink Sheet Forecast - Price Action Indicator
| SPHDFDelisted Stock | USD 13.35 0.00 0.00% |
Santhera Pink Sheet outlook is based on your current time horizon. We recommend always using this module together with an analysis of Santhera Pharmaceuticals' historical fundamentals, such as revenue growth or operating cash flow patterns.
As of 28th of January 2026 The relative strength index (RSI) of Santhera Pharmaceuticals' share price is above 80 . This usually implies that the pink sheet is significantly overbought by investors. The fundamental principle of the Relative Strength Index (RSI) is to quantify the velocity at which market participants are driving the price of a financial instrument upwards or downwards. Momentum 100
Buy Peaked
Oversold | Overbought |
Using Santhera Pharmaceuticals hype-based prediction, you can estimate the value of Santhera Pharmaceuticals Holding from the perspective of Santhera Pharmaceuticals response to recently generated media hype and the effects of current headlines on its competitors.
Santhera Pharmaceuticals after-hype prediction price | USD 13.35 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as pink sheet price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Santhera |
Santhera Pharmaceuticals Additional Predictive Modules
Most predictive techniques to examine Santhera price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Santhera using various technical indicators. When you analyze Santhera charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Check Santhera Pharmaceuticals Volatility | Backtest Santhera Pharmaceuticals | Information Ratio |
Santhera Pharmaceuticals Trading Date Momentum
| On January 28 2026 Santhera Pharmaceuticals Holding was traded for 13.35 at the closing time. The highest daily price throughout the period was 13.35 and the lowest price was 13.35 . There was no trading activity during the period 0.0. Lack of trading volume on 01/28/2026 did not result in any price rise and fall. The trading price change to current closing price is 0.00% . |
Price Action Indicator (or PAIN) was developed by Michael B. Geraty and published in 'Futures' magazine in August 1997.
Compare Santhera Pharmaceuticals to competition
Santhera Pharmaceuticals Related Equities
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Santhera Pharmaceuticals pink sheet to make a market-neutral strategy. Peer analysis of Santhera Pharmaceuticals could also be used in its relative valuation, which is a method of valuing Santhera Pharmaceuticals by comparing valuation metrics with similar companies.
| Risk & Return | Correlation |
Santhera Pharmaceuticals Market Strength Events
Market strength indicators help investors to evaluate how Santhera Pharmaceuticals pink sheet reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Santhera Pharmaceuticals shares will generate the highest return on investment. By undertsting and applying Santhera Pharmaceuticals pink sheet market strength indicators, traders can identify Santhera Pharmaceuticals Holding entry and exit signals to maximize returns.
Santhera Pharmaceuticals Risk Indicators
The analysis of Santhera Pharmaceuticals' basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in Santhera Pharmaceuticals' investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting santhera pink sheet prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
| Mean Deviation | 0.2636 | |||
| Standard Deviation | 1.45 | |||
| Variance | 2.11 |
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
Story Coverage note for Santhera Pharmaceuticals
The number of cover stories for Santhera Pharmaceuticals depends on current market conditions and Santhera Pharmaceuticals' risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Santhera Pharmaceuticals is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Santhera Pharmaceuticals' long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Other Macroaxis Stories
Our audience includes start-ups and big corporations as well as marketing, public relation firms, and advertising agencies, including technology and finance journalists. Our platform and its news and story outlet are popular among finance students, amateur traders, self-guided investors, entrepreneurs, retirees and baby boomers, academic researchers, financial advisers, as well as professional money managers - a very diverse and influential demographic landscape united by one goal - build optimal investment portfolios
Story Categories
Currently Trending Categories
Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in small area income & poverty estimates. You can also try the Portfolio Holdings module to check your current holdings and cash postion to detemine if your portfolio needs rebalancing.
Other Consideration for investing in Santhera Pink Sheet
If you are still planning to invest in Santhera Pharmaceuticals check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Santhera Pharmaceuticals' history and understand the potential risks before investing.
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets |